Research Area 003 - Advanced Development of Vaccine Candidates for Biodefense and Emerging Infectious Diseases

Predicted recompete opportunity based on federal award data.
Current Contract: 75N93019C00055 Incumbent: UNIVERSITY OF MARYLAND, BALTIMORE Contract Value: $33,236,281.46 Potential End Date: 2026-09-15T00:00:00.000Z Competition: FULL AND OPEN COMPETITION Pricing: COST NO FEE Classification: full-recompete (Confidence: high - 90/100)
National Institute of Allergy & Infectious Diseases (NIAID) 2018 Omnibus Broad Agency Announcement - HHS-NIH-NIAID-BAA2018 Activity Log: 1. Solicitation Issuance: 06/01/2018 2. Amendment No.1 Issuance: 07/03/2018 - Purpose of Amendment 1: To add RESEARCH AREA 003, "Collaborative Influenza Vaccine Innovation Centers (CIVICs)" to the 2018 Omnibus Broad Agency Announcement - Included Attachments: Revised solicitation: "HHS-NIH-NIAID-BAA2018 - Amendment One" 3. Amendment No.2 Issuance: 07/03/2018 - Purpose of Amendment 2: To provide responses to questions received regarding Research Areas 001 and 002 of this solicitation. 4. Amendment No.3 Issuance: 07/20/2018 - Purpose of Amendment 3: This amendment is applicable to RESEARCH AREA 003, "Collaborative Influenza Vaccine Innovation Centers (CIVICs)". This amendment provides a Government point of contact for organizations wishing to advertise their interest in collaborating with other interested organizations. Michael C. Finn, M.B.A., Chief Contracting Officer Phone: +1 (555) 000-0000 Email: contact@example.gov 5. Amendment No.4 Issuance: 07/24/2018 - Purpose of Amendment 4: To provide responses to questions received regarding Research Areas 001 and 002 of this solicitation. 6. Amendment No.5 Issuance: 08/02/2018 - Purpose of Amendment 5: To revise solicitation HHS-NIH-NIAID-BAA2018; clarifying that the PHS Human Subjects and Clinical Trials Information Form is NOT included in the Technical Proposal page limit, and providing updated hyperlinks within the solicitation. - Included Attachments: Revised solicitation: "HHS-NIH-NIAID-BAA2018, Amendment 1 (Revised 08-02-2018)" 7. Amendment No.6 Issuance: 08/31/2018 - Purpose of Amendment 6: This amendment is applicable to RESEARCH AREA 003, "Collaborative Influenza Vaccine Innovation Centers (CIVICs)". The purpose of this amendment is to revise Section 3.2 of solicitation HHS-NIH-NIAID-BAA2018, and provide responses to questions received in response to Research Area 003. - Included Attachments: Revised solicitation: "HHS-NIH-NIAID-BAA2018, Amendment 1 (Revised 08-31-2018)" 8. Amendment No.7 Issuance: 08/31/2018 - Purpose of Amendment 7: This informational amendment is applicable to RESEARCH AREA 003, "Collaborative Influenza Vaccine Innovation Centers (CIVICs)". This purpose of this informational amendment is to make available contact information provided by organizations wishing to advertise their interest in collaborating with other interested organizations. - Included Attachments: "Organizations Advertising Their Interest in Collaborating" 9. Amendment No.8 Issuance: 10/24/2018 - Purpose of Amendment 8: This amendment is applicable to RESEARCH AREA 003, "Collaborative Influenza Vaccine Innovation Centers (CIVICs)". This purpose of this amendment is to revise Section 3.2.3.4. UNIFORM COST ASSUMPTIONS, and provide responses to questions received in response to Research Area 003. 10. Amendment No.9 Issuance: 11/05/2018 - Purpose of Amendment 9: This amendment is applicable to RESEARCH AREA 003, "Collaborative Influenza Vaccine Innovation Centers (CIVICs)". This purpose of this amendment is to revise Section 3.2.3.4. UNIFORM COST ASSUMPTIONS, and provide responses to questions received in response to Research Area 003.